Tackling sundowning in a patient with Alzheimer's disease.
The early evening exacerbation of behavioral symptoms in sundowning has been recognized by medical professionals as a challenge. The circadian, hormonal, physiological, and environmental correlations with sundowning behaviors are described.
Sharer
Janine
J
Indiana University of Pennsylvania, Indiana, PA, USA.
D000368:Aged; D000544:Alzheimer Disease / Q000150:complications*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D002940:Circadian Rhythm; D003693:Delirium / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D015577:Geriatric Assessment; D006801:Humans; D008550:Melatonin / Q000627:therapeutic use; D024802:Nurse's Role; D009730:Nursing Assessment; D010789:Phototherapy; D011322:Primary Prevention; D011595:Psychomotor Agitation / Q000209:etiology / Q000517:prevention & control*; D012307:Risk Factors; D013997:Time Factors
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D008550:Melatonin